Trump administration reclassifies medical marijuana as a 'less-dangerous drug'

Trump administration reclassifies medical marijuana as less-dangerous drug, easing research and tax rules without full legalisation. | Contesto: cronaca

Punti chiave

• Trump administration reclassifies medical marijuana as a 'less-dangerous drug'

Contesto

The Trump administration on Thursday reclassified state-licensed medical marijuana as a less-dangerous drug, a move that eases longstanding research barriers and grants tax relief to cannabis businesses operating legally under state law. The decision, announced by the Drug Enforcement Administration, shifts marijuana from Schedule I to Schedule III under the Controlled Substances Act, acknowledging that the drug has accepted medical uses and a lower potential for abuse than previously classified. The change stops short of federal legalisation, meaning that recreational use remains illegal nationwide and that federal criminal penalties for unauthorised possession or distribution still apply. The reclassification represents the most significant revision to federal cannabis policy in decades. Under Schedule I, marijuana was grouped with heroin and LSD, substances deemed to have no medical value and a high risk of abuse. That classification had long been criticised by researchers and medical professionals for stifling scientific study into the drug's potential benefits and risks. The new Schedule III status, shared with drugs such as Tylenol with codeine and anabolic steroids, will remove some of the most onerous federal restrictions on research and allow state-licensed dispensaries to deduct ordinary business expenses on their federal taxes, a change that could significantly lower their financial burdens. Advocates for medical marijuana praised the move as a long-overdue acknowledgment of the drug's therapeutic value for conditions such as chronic pain, epilepsy, and nausea associated with chemotherapy. They noted that the change could accelerate clinical trials and help standardise dosing and safety protocols. However, critics, including some conservative lawmakers and anti-drug organisations, argued that the reclassification could send mixed signals about the dangers of marijuana, particularly to young people, and that it might pave the way for broader legalisation efforts at the state level. The policy shift comes amid a rapidly changing landscape for cannabis in the United States. More than 40 states now allow some form of medical marijuana, and 24 states plus...

Lettura DEO

Decisione di validazione: publish

Risk score: 0.0

Il testo è stato ricostruito dai dati editoriali disponibili senza aggiungere fatti non presenti nel record sorgente.

Indicatore di affidabilità

Verificata — Alta confidenza. Fonti affidabili confermano la notizia.

Il sistema a semaforo

Ogni articolo su DEO include un indicatore di affidabilità:

• 🟢 Verificata — Alta confidenza. Fonti affidabili confermano la notizia.
• 🟡 In evoluzione — Confidenza moderata. Alcuni dettagli potrebbero ancora cambiare.
• 🔴 Contestata — Bassa confidenza. Fonti in conflitto o incertezze rilevanti.

Questo sistema esiste perché chi legge merita di sapere non solo cosa è successo, ma anche quanto la notizia è solida.

Categoria: cronaca